Palmetto GBA Executive and Leadership Team

Mike Gurrera, the Vice President & Amp. Chief Financial Officer at Palmetto GBA, directs the company's financial strategy and operations. Gurrera oversees all fiscal activities, including budgeting, financial planning, and reporting, ensuring the financial health and stability of the organization. This leadership position involves managing financial risks and identifying opportunities for cost optimization and revenue enhancement. Gurrera's responsibilities extend to capital allocation and investment strategies, aligning financial resources with the company's long-term objectives. The Chief Financial Officer role is critical in supporting Palmetto GBA's mission of providing efficient claims and transaction processing services. Mike Gurrera ensures robust financial controls are in place to meet the demands of federal government and commercial contracts. This executive drives financial performance through meticulous analysis and strategic decision-making, contributing directly to the company's operational success and market position.

Nancy Lybrand, the Vice President & Chief Financial Officer at Palmetto GBA, manages the organization's financial health and strategic fiscal planning. Lybrand oversees all financial operations, including accounting, financial reporting, and compliance, ensuring adherence to stringent government and commercial standards. This executive role involves developing financial models, managing budgets, and optimizing financial performance to support Palmetto GBA's extensive claims and transaction processing services. Nancy Lybrand plays a key part in financial risk management and capital investment decisions, driving profitability and sustainability. The Chief Financial Officer's guidance is essential for the company's growth and operational efficiency. Lybrand's expertise ensures that financial resources are allocated effectively to support contact center operations and technical services. This executive's strategic financial leadership underpins the company's ability to serve its clients reliably.

Nella Bishop, the Vice President and Chief Information Officer, Systems and Support at Palmetto GBA, architects the company's technology infrastructure and information systems. Bishop leads the strategic direction for all IT operations, ensuring the reliability, security, and scalability of systems that support high-volume claims and transaction processing. This role encompasses overseeing technology development, system maintenance, and technical support services for both federal government and commercial clients. Nella Bishop drives innovation in IT solutions, enhancing operational efficiency and data integrity. The Chief Information Officer is pivotal in safeguarding sensitive information and ensuring compliance with regulatory requirements. Bishop's leadership ensures that Palmetto GBA's technological capabilities meet the evolving demands of the market, supporting seamless contact center operations and advanced technical services. This executive's focus on robust systems underpins the company's ability to deliver critical services effectively.

Margaret Price, the Vice President & Chief Technology Officer at Palmetto GBA, spearheads the company's technological advancements and innovation. Price directs the development and implementation of cutting-edge technologies that enhance Palmetto GBA's service offerings in claims processing, contact center operations, and technical services. This executive is responsible for evaluating emerging technologies and integrating them to improve operational efficiency and client satisfaction. Margaret Price ensures that the company's technology strategy aligns with its business objectives, supporting the delivery of high-volume transaction processing for government and commercial sectors. The Chief Technology Officer role involves fostering a culture of technological excellence and driving digital transformation initiatives. Price's leadership is crucial for maintaining Palmetto GBA's competitive edge through superior technological solutions. This executive's vision guides the company's technological roadmap, ensuring robust and scalable systems.

Miguel Brito, the Chief Medical Officer at Palmetto GBA, provides critical medical expertise and oversight for the company's operations. Brito guides the interpretation and application of medical policies and guidelines within the context of claims processing and healthcare services. This role is essential for ensuring that Palmetto GBA's services align with medical best practices and regulatory requirements, particularly for federal government contracts. Miguel Brito's insights inform the development of protocols and procedures related to medical review and health services. The Chief Medical Officer's responsibilities include advising on clinical aspects of transaction processing and supporting the technical services division with medical knowledge. Brito's leadership ensures the integrity and accuracy of medical data handled by the organization. This executive's focus on clinical accuracy supports Palmetto GBA's mission to deliver reliable services.

Gabriel Bien-Willner, the Medical Director & Chief Medical Officer, Moldx, Palmetto Gba, directs specialized medical oversight for molecular diagnostics services. Bien-Willner leads the clinical strategy and quality assurance for Moldx operations, ensuring adherence to the highest medical and scientific standards. This executive role involves guiding the interpretation of complex diagnostic data and ensuring accurate reporting for clients. Gabriel Bien-Willner's expertise is crucial for Palmetto GBA's specialized services, particularly in supporting federal government initiatives requiring precise medical evaluations. The Chief Medical Officer's responsibilities include collaborating with technical teams to optimize diagnostic processes and reporting systems. Bien-Willner's leadership ensures the integrity of molecular diagnostic services, contributing to informed healthcare decisions. This executive's focus on specialized medical services enhances Palmetto GBA's capabilities.

Jacqueline Lekostaj, the Chief Medical Officer, Molecular Diagnostics at Palmetto GBA, provides strategic medical leadership for the company's molecular diagnostics division. Lekostaj oversees the clinical integrity and operational effectiveness of diagnostic services, ensuring compliance with all relevant medical and regulatory standards. This executive role involves guiding the development and implementation of advanced diagnostic protocols and technologies. Jacqueline Lekostaj's contributions are vital for Palmetto GBA's ability to offer specialized molecular diagnostic solutions to government and commercial clients. The Chief Medical Officer's focus is on enhancing the accuracy and efficiency of diagnostic testing and reporting. Lekostaj drives medical excellence within the division, supporting informed decision-making through precise diagnostic insights. This executive's leadership ensures the high quality of Palmetto GBA's specialized medical services.

Angella Charnot- Katsikas, the Medical Director & Chief Medical Officer, Moldx at Palmetto GBA, leads clinical operations and medical strategy for the molecular diagnostics unit. Charnot- Katsikas ensures the highest standards of medical practice and scientific rigor in all Moldx activities. This executive role involves overseeing the quality control of diagnostic testing and the interpretation of results, supporting Palmetto GBA's commitment to accurate service delivery. Angella Charnot- Katsikas provides critical medical guidance that enhances the company's technical services in specialized areas. The Chief Medical Officer's responsibilities include staying abreast of advancements in molecular diagnostics to maintain a leading edge. Charnot- Katsikas's leadership ensures that Palmetto GBA's diagnostic services meet the complex needs of its clientele, including federal agencies. This executive's dedication to medical excellence strengthens the company's specialized offerings.

Magdalena Karandikar, the Medical Director & Chief Medical Officer, Moldx & Palmetto Gba, provides comprehensive medical leadership across specialized diagnostics and broader company operations. Karandikar directs clinical strategy and ensures the highest medical integrity for molecular diagnostics services, while also contributing medical insights to overall company initiatives. This executive role involves guiding the accurate interpretation of diagnostic data and ensuring compliance with stringent healthcare regulations. Magdalena Karandikar's dual focus enhances Palmetto GBA's capacity to deliver precise and reliable services to government and commercial partners. The Chief Medical Officer's responsibilities include fostering innovation in diagnostic methodologies and supporting the technical services team with medical expertise. Karandikar's leadership ensures that Palmetto GBA maintains its reputation for quality and accuracy in all medical-related operations. This executive's strategic medical direction is vital for the company's success.